Pfizer fends off generic Detrol LA from Impax
This article was originally published in Scrip
Pfizer has confirmed it has settled its patent infringement suit against Impax, which had in 2008 sought to make generic versions of Pfizer's antimuscarinic Detrol LA (tolterodine extended release) for over active bladder.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.